Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00510315 · ClinicalTrials.gov registry record

Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
11
Enrollment target

NCT00510315: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00510315 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00510315 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
11 participants
Enrollment target

Study Summary

The purpose of this study is to better understand why some women who survived cancer or a related illness later develop diabetes, problems with their cholesterol, or other problems that may lead to heart disease. Because these problems may be related to treatment with total body irradiation and a stem cell transplant, the investigators will compare the rates of obesity, cholesterol problems, and diabetes between women who were treated with total body irradiation and a stem cell transplant and women who were not. The amount and location of fat stores in the abdomen is more important than overall weight or total body fat in the development of diabetes and cholesterol problems. In general, fat can be stored in several areas in the abdomen: around the organs (visceral fat), under the skin (subcutaneous fat), and in the liver (liver fat). People with higher amounts of fat around the organs (visceral fat), even those with a normal weight, are more likely to become diabetic or have high cholesterol. The amount of fat in each of these areas can be measured with an abdominal magnetic resonance imaging (MRI). In this study, the investigators will use blood tests, height, weight, waist circumference, blood pressure measurements, and an abdominal MRI to evaluate for several risk factors of heart disease, including cholesterol problems, diabetes and pre-diabetes, elevated blood pressure, and increased abdominal fat.

Interventions

  • OTHER Questionnaires, Laboratory tests, Abdominal MRI

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2007-07
Est. Completion 2016-01

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00510315

The ClinicalTrials.gov registry entry for NCT00510315 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Questionnaires, Laboratory tests, Abdominal MRI is the first listed.

NCT00510315 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00510315 about?

NCT00510315 is a clinical study titled "Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant". The purpose of this study is to better understand why some women who survived cancer or a related illness later develop diabetes, problems with their cholesterol, or other problems that may lead to heart disease. Because these problems may be related to treatment with total body irradiation and a st...

What is the current status of trial NCT00510315?

This trial is currently completed. The enrollment target is 11 participants. The study started on 2007-07. Estimated completion is 2016-01.

What interventions are being tested in trial NCT00510315?

The interventions under investigation include: Questionnaires, Laboratory tests, Abdominal MRI (OTHER).

Who is sponsoring clinical trial NCT00510315?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.